Which members of Congress traded AbbVie ABBV recently?

The latest reported trades: Rep. Pete Sessions, full sale on 09/14 (reported 09/18), Sen. Alan Armstrong, purchase on 03/27 (reported 07/21), Rep. Josh Gottheimer, full sale on 05/05 (reported 06/03), Rep. Julie Johnson, full sale on 25/12/18 (reported 01/15) and Rep. Julia Letlow, full sale on 25/12/08 (reported 01/13).

Stocks

AbbVie ABBV

Health care sectorNYSE

What to see in AbbVie now

Is Wall Street adding or cutting?+106

4,210 13F filers hold it · +106 against the quarter before · shares held +2.7%

Holdings of 06/30

Are members of Congress buying or selling?2

2 members of Congress traded it in 90 days · 1 purchases · 1 sales

Reported 09/18

How much more do Koreans hold through ETFs?$94.6M

Koreans hold $94.6M more through 6 ETFs

Holdings of 06/30

Close: $261.94; 09/30 close
Day change: −0.5%; vs previous close
Volume: 126,056; −44.0% vs 30-day average
52-week range: $191.33$269.25
1-year return: +13.1%; vs the close a year ago
Market cap: $462.9B; 1,767,117,285 shares · reported 07/27

Company

Exchange: NYSE
Sector: Health care
Industry: Pharmaceutical Preparations
Headquarters: North Chicago, Illinois
Fiscal year end: 12/31
Next earnings: 08/28, estimated

4,210 13F filers hold it · +106 against the quarter before · shares held +2.7%Holdings of 06/30

Funds

13F filers: 4,210 · +106 since the quarter before · 06/30 holdings

Famous funds that held AbbVie in their latest 13F report.

Fund	Shares	Value	Share of the portfolio	Since the quarter before
National Pension ServiceAbbVie ABBV · 06/30 holdings	4,009,573 sh	$1B	0.7%	Added +1.5%
Korea InvestmentAbbVie ABBV · 06/30 holdings	1,291,102 sh	$324.9M	0.6%	Added +1.9%
Mirae Asset Global InvestmentsAbbVie ABBV · 06/30 holdings	495,003 sh	$124.6M	0.2%	Added +5.8%
Mirae Asset Global ETFS HoldingsAbbVie ABBV · 06/30 holdings	224,280 sh	$56.4M	0.1%	No quarter before
Bridgewater AssociatesAbbVie ABBV · 06/30 holdings	11,775 sh	$3M	<0.1%	Trimmed −61.2%

All tracked funds

5% stakes

	Holder			Kind
04/29	Vanguard Capital Management04/29	7.51%132,924,058 sh	First report	13G passive
03/26	Vanguard Group03/26	0%0 sh	−10.0pp	13G passiveAmendment

All 5% stake reports on AbbVie

Price

$261.94Day −0.5%1 year +13.1%

26-week trading

Members of Congress reported 2 trades in AbbVie ABBV in the past 90 days (1 purchase, 1 sale).

Common questions

Which members of Congress traded AbbVie ABBV recently?: The latest reported trades: Rep. Pete Sessions, full sale on 09/14 (reported 09/18), Sen. Alan Armstrong, purchase on 03/27 (reported 07/21), Rep. Josh Gottheimer, full sale on 05/05 (reported 06/03), Rep. Julie Johnson, full sale on 25/12/18 (reported 01/15) and Rep. Julia Letlow, full sale on 25/12/08 (reported 01/13).